Detalhe da pesquisa
1.
Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma.
Eur Respir J
; 55(5)2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32060061
2.
The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma.
Eur Respir J
; 62(2)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37474156
3.
Sleep and asthma.
Curr Opin Pulm Med
; 24(6): 569-573, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30199406
4.
Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy.
Eur Respir J
; 57(6)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33632798
5.
Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma.
Allergy
; 76(7): 2238-2241, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33432682
6.
Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthma.
Allergy
; 76(6): 1890-1893, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33300186
7.
Adult and paediatric cough guidelines: Ready for an overhaul?
Pulm Pharmacol Ther
; 35: 137-44, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25681276
8.
Idiopathic pulmonary fibrosis-associated cough: Mechanisms and management.
Pulm Pharmacol Ther
; 56: 100-103, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30930174
9.
A pragmatic guide to choosing biologic therapies in severe asthma.
Breathe (Sheff)
; 17(4): 210144, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35296105
10.
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma.
Chest
; 159(2): 496-506, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32882249
11.
Real-World Effectiveness of Anti-IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization.
J Allergy Clin Immunol Pract
; 9(6): 2315-2320.e1, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33689868
12.
Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis.
ERJ Open Res
; 6(4)2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33263051
13.
Real-World Effectiveness and the Characteristics of a "Super-Responder" to Mepolizumab in Severe Eosinophilic Asthma.
Chest
; 158(2): 491-500, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32275980
14.
Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis.
ERJ Open Res
; 6(1)2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31984211
15.
Over- and under-diagnosis in asthma.
Breathe (Sheff)
; 15(1): e20-e27, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31031841
16.
Treatment of Interstitial Lung Disease Associated Cough: CHEST Guideline and Expert Panel Report.
Chest
; 154(4): 904-917, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30036496
17.
The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma.
J Allergy Clin Immunol Pract
; 9(5): 2093-2096.e1, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33486140